Africa Daily Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Daily Journal.

Press releases published on November 4, 2026

6 hours ago

CIMA names KilimoChills Solution inaugural Lions' Lair Africa winner at ENGAGE Africa 2026

Indeterminate EIN Presswire

11 hours ago

Errachidia Mayor Joins 2026 Global Mayors Dialogue in Ningbo

Indeterminate EIN Presswire

12 hours ago

XS.com nomeia Hanna Le como Diretora de Desenvolvimento de Negócios para o Vietnã

Indeterminate EIN Presswire

12 hours ago

Jelili Atiku to Perform in Lagos as 1922 Revisited Opens West Africa Edition

Indeterminate EIN Presswire

2 hours ago

Ichnos Glenmark Innovation (IGI) to Present Updated Clinical Data for ISB 2001 (ABBV-2001) in Relapsed/Refractory Multiple Myeloma at 68th ASH Annual Meeting

Indeterminate GlobeNewswire

3 hours ago

High-Grade Gold Near Surface at Duquesne West Including 7.0 g/t over 24.8 m

Indeterminate GlobeNewswire

3 hours ago

ORYZON to Present Updated Positive Clinical Data for Iadademstat in Hematological Malignancies at ASH 2026

Indeterminate GlobeNewswire

3 hours ago

Translational Data from Anal Cancer Patients Show Pelareorep Drives HPV-Specific Immune Responses, Supporting its Potential Across HPV-Driven Cancers

Indeterminate GlobeNewswire

4 hours ago

Solu Therapeutics to Present Initial Phase 1 Results of STX-0712 and New Preclinical Data on STX-0640 in Two Oral Presentations at the 2026 ASH Annual Meeting

Indeterminate GlobeNewswire

4 hours ago

Lyell Immunopharma Announces $80 Million Private Placement to Advance Ronde-Cel Toward Planned BLA Submission

Indeterminate GlobeNewswire

4 hours ago

Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) will be Presented at the 68ᵗʰ American Society for Hematology Annual Meeting & Exposition

Indeterminate GlobeNewswire

4 hours ago

Secura Bio Announces Two Duvelisib Presentations on Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma at the 2026 American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire

4 hours ago

Agios to Highlight Strength and Differentiation of Rare Hematology Portfolio with New Clinical Data for Mitapivat in Sickle Cell Disease and AG-236 in Polycythemia Vera at ASH 2026

Indeterminate GlobeNewswire

4 hours ago

Lyell Immunopharma to Present Positive Updated Ronde-Cel Data in More than 80 Patients at ASH 2026 from PiNACLE Pivotal Trial in 3L+ and from Phase 1/2 2L Cohort in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Indeterminate GlobeNewswire

4 hours ago

SELLAS Life Sciences to Present Positive Phase 2 Data Demonstrating Encouraging Response and Survival Outcomes with SLS009 Combination in High-Risk AML at ASH 2026

Indeterminate GlobeNewswire

4 hours ago

Clene Reports Third Quarter 2026 Financial Results and Recent Operating Highlights

Indeterminate GlobeNewswire

4 hours ago

Aprea Therapeutics Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

4 hours ago

Tango and Erasca Initiate Phase 1/2 Study of Oral PRMT5 Inhibitor Vopimetostat in Combination with Pan-RAS Molecular Glue ERAS-0015

Indeterminate GlobeNewswire

5 hours ago

Rhythm Pharmaceuticals Announces NICE Guidance for IMCIVREE® (Setmelanotide) Updated to Include Adults Living with Bardet-Biedl Syndrome

Indeterminate GlobeNewswire

5 hours ago

Electra Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire